Kinetic glucose determination with glucose dehydrogenase

Rindfrey, H; Helger, R.; Lang, Hermann

doi:10.1007/bf00440835

Cited by 4 publications

(3 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The blood glucose concentration was determined with a glucose dehydrogenase method (12) and the haemoglobin concentration was measured with Advia 120 (Bayer, Tarrytown, NY, USA).…”

Section: Methodsmentioning

confidence: 99%

A new transcutaneous bilirubinometer, BiliCheck, used in the neonatal intensive care unit and the maternity ward

2002

View full text Add to dashboard Cite

show abstract

“…The blood glucose concentration was determined with a glucose dehydrogenase method (12) and the haemoglobin concentration was measured with Advia 120 (Bayer, Tarrytown, NY, USA).…”

Section: Methodsmentioning

confidence: 99%

A new transcutaneous bilirubinometer, BiliCheck, used in the neonatal intensive care unit and the maternity ward

2002

View full text Add to dashboard Cite

show abstract

“…The samples were analysed by the glucose dehydrogenase photometric method6 in an Hitachi 911 analyser with an analytical standard deviation of 0.08 mmol/l both within and between series and a combined preanalytical and analytical standard deviation of 0.15 mmol/l, both within day and day to day.…”

Section: Methodsmentioning

confidence: 99%

Blood glucose levels in a population of healthy, breast fed, term infants of appropriate size for gestational age

Hoseth

2000

Archives of Disease in Childhood - Fetal and Neonatal Edition

123

View full text Add to dashboard Cite

Aim-To determine blood glucose levels in a population of healthy, breast fed, term infants of appropriate size for gestational age. Methods-In a cross sectional study, the blood glucose concentration of 223 healthy, breast fed, term infants of appropriate size for gestational age was determined at diVerent times (between one and 96 hours) after delivery. One sample of blood glucose was taken from each infant independent of the feeding time. The glucose concentration was correlated with sex, method of delivery, delivery with or without analgesia, smoking status of the mother, gestational age, umbilical cord pH, and Apgar score. Infants suspected of suVering from intrapartum hypoxia were excluded. Results-Blood glucose concentration one hour after delivery was not significantly lower than at any other time. Only two infants had low blood glucose concentrations one hour after delivery (1.4 and 1.9 mmol/l). There were no significant diVerences in blood glucose concentration between sexes, methods of delivery, infants delivered with or without analgesia, and infants born to smokers or non-smokers, and there was no further correlation between blood glucose concentration and gestational age, umbilical cord pH, or Apgar score. Discussion-Very few healthy, breast fed, term infants of appropriate size for gestational age have low blood glucose levels, and there is no indication for blood glucose monitoring in these infants.

show abstract

“…Glucose concentration was measured using the glucose dehydrogenase photometric method on an Hitachi 911 analyser 8. The day to day combined preanalytical and analytical standard deviation was 0.15 mmol/l.…”

Section: Methodsmentioning

confidence: 99%

Neonatal hypoglycaemia and withdrawal symptoms after exposure in utero to valproate

Ebbesen

Joergensen

Hoseth

et al. 2000

Archives of Disease in Childhood - Fetal and Neonatal Edition

View full text Add to dashboard Cite

Aims-To define, in a prospective study, the risk of hypoglycaemia-defined as blood glucose concentration < 1.8 mmol/ l-in term infants exposed in utero to valproate and to describe the withdrawal symptoms. Methods-Twenty epileptic women were treated with valproate only during pregnancy and two were treated with valproate and carbamazepine. In the first trimester, the daily median dose of valproate was 1.0 g (range 0.3-4.2) and in the third trimester 1.2 g (range 0.3-4.8).Results-Thirteen of the 22 infants became hypoglycaemic. One infant had eight episodes of hypoglycaemia, one had three episodes, two had two episodes, and nine had one episode each. The lowest blood glucose concentration was 1.0 mmol/l. All episodes were asymptomatic. The maternal mean plasma concentration of total valproate during the third trimester correlated negatively with blood glucose concentration one hour after delivery (p < 0.0003) and with the development of hypoglycaemia (p < 0.0001). There was no evidence for hyperinsulinaemia as the cause of hypoglycaemia. Ten infants developed withdrawal symptoms, which correlated positively with the mean dose of valproate in the third trimester and the concentration of the free fraction of valproate in maternal plasma at delivery (p < 0.02). Conclusions-Infants exposed to valproate in utero had a significantly elevated risk of hypoglycaemia, and withdrawal symptoms were often observed. (Arch Dis Child Fetal Neonatal Ed 2000;83:F124-F129)

show abstract

Kinetic glucose determination with glucose dehydrogenase

Cited by 4 publications

References 1 publication

A new transcutaneous bilirubinometer, BiliCheck, used in the neonatal intensive care unit and the maternity ward

A new transcutaneous bilirubinometer, BiliCheck, used in the neonatal intensive care unit and the maternity ward

Blood glucose levels in a population of healthy, breast fed, term infants of appropriate size for gestational age

Neonatal hypoglycaemia and withdrawal symptoms after exposure in utero to valproate

Contact Info

Product

Resources

About